Long-Term Outcomes of Patients With BRCA+ or PALB2+ Pancreatic Cancer Treated With Maintenance Rucaparib: A Secondary Analysis of a Nonrandomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Long-Term Outcomes of Patients With BRCA+ or PALB2+ Pancreatic Cancer Treated With Maintenance Rucaparib: A Secondary Analysis of a Nonrandomized Clinical Trial.
Authors: Reiss KA; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia., Xia M; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Translational Medicine and Human Genetics, University of Pennsylvania, Philadelphia., Akamandisa M; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Translational Medicine and Human Genetics, University of Pennsylvania, Philadelphia.; Department of Genetics, Yale University, New Haven, Connecticut., D'Andrea K; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Translational Medicine and Human Genetics, University of Pennsylvania, Philadelphia., Wubbenhorst B; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Translational Medicine and Human Genetics, University of Pennsylvania, Philadelphia., Lord CJ; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Pettitt SJ; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Tutt ANJ; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Brown TJ; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Hematology/Oncology, University of Texas Southwestern, Dallas., O'Hara MH; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia., Schneider C; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia., Teitelbaum U; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia., Hannan Z; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.; Internal Medicine Residency Program, Main Line Health System, Philadelphia, Pennsylvania., Hood R; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.; Miller School of Medicine, University of Miami, Miami, Florida., Tondon R; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia., Vonderheide RH; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia., Domchek SM; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.; The Basser Center for BRCA, University of Pennsylvania, Philadelphia., Nathanson KL; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Translational Medicine and Human Genetics, University of Pennsylvania, Philadelphia.; The Basser Center for BRCA, University of Pennsylvania, Philadelphia.
Source: JAMA oncology [JAMA Oncol] 2026 Jun 01; Vol. 12 (6), pp. 666-670.
Publication Type: Journal Article
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42060271
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Long-Term Outcomes of Patients With BRCA+ or PALB2+ Pancreatic Cancer Treated With Maintenance Rucaparib: A Secondary Analysis of a Nonrandomized Clinical Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Reiss+KA%22">Reiss KA</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Xia+M%22">Xia M</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Translational Medicine and Human Genetics, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Akamandisa+M%22">Akamandisa M</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Translational Medicine and Human Genetics, University of Pennsylvania, Philadelphia.; Department of Genetics, Yale University, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22D'Andrea+K%22">D'Andrea K</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Translational Medicine and Human Genetics, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Wubbenhorst+B%22">Wubbenhorst B</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Translational Medicine and Human Genetics, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Lord+CJ%22">Lord CJ</searchLink>; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22Pettitt+SJ%22">Pettitt SJ</searchLink>; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22Tutt+ANJ%22">Tutt ANJ</searchLink>; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22Brown+TJ%22">Brown TJ</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Hematology/Oncology, University of Texas Southwestern, Dallas.<br /><searchLink fieldCode="AU" term="%22O'Hara+MH%22">O'Hara MH</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Schneider+C%22">Schneider C</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Teitelbaum+U%22">Teitelbaum U</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Hannan+Z%22">Hannan Z</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.; Internal Medicine Residency Program, Main Line Health System, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Hood+R%22">Hood R</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.; Miller School of Medicine, University of Miami, Miami, Florida.<br /><searchLink fieldCode="AU" term="%22Tondon+R%22">Tondon R</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Vonderheide+RH%22">Vonderheide RH</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Domchek+SM%22">Domchek SM</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.; The Basser Center for BRCA, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Nathanson+KL%22">Nathanson KL</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Translational Medicine and Human Genetics, University of Pennsylvania, Philadelphia.; The Basser Center for BRCA, University of Pennsylvania, Philadelphia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101652861%22">JAMA oncology</searchLink> [JAMA Oncol] 2026 Jun 01; Vol. 12 (6), pp. 666-670.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101652861 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2374-2445 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223742437%22">23742437 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Oncol <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42060271
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamaoncol.2026.0870
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 666
    Titles:
      – TitleFull: Long-Term Outcomes of Patients With BRCA+ or PALB2+ Pancreatic Cancer Treated With Maintenance Rucaparib: A Secondary Analysis of a Nonrandomized Clinical Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Reiss KA
      – PersonEntity:
          Name:
            NameFull: Xia M
      – PersonEntity:
          Name:
            NameFull: Akamandisa M
      – PersonEntity:
          Name:
            NameFull: D'Andrea K
      – PersonEntity:
          Name:
            NameFull: Wubbenhorst B
      – PersonEntity:
          Name:
            NameFull: Lord CJ
      – PersonEntity:
          Name:
            NameFull: Pettitt SJ
      – PersonEntity:
          Name:
            NameFull: Tutt ANJ
      – PersonEntity:
          Name:
            NameFull: Brown TJ
      – PersonEntity:
          Name:
            NameFull: O'Hara MH
      – PersonEntity:
          Name:
            NameFull: Schneider C
      – PersonEntity:
          Name:
            NameFull: Teitelbaum U
      – PersonEntity:
          Name:
            NameFull: Hannan Z
      – PersonEntity:
          Name:
            NameFull: Hood R
      – PersonEntity:
          Name:
            NameFull: Tondon R
      – PersonEntity:
          Name:
            NameFull: Vonderheide RH
      – PersonEntity:
          Name:
            NameFull: Domchek SM
      – PersonEntity:
          Name:
            NameFull: Nathanson KL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2026 Jun 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2374-2445
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: JAMA oncology
              Type: main
ResultId 1